Companies / Calidi Biotherapeutics, Inc.

Calidi Biotherapeutics, Inc.

NYSECIK 1855485SAN DIEGO, CA

Financials · FY2023

Revenue$45.0K
Net income$-20.06M
Total debt$600.0K
Cash$9.60M
Diluted EPS$-5.95
Shares outstanding19.3M

Ownership

19.3M shares outstanding · as of May 8, 2026
100.0%Public float
Ownership
Public float100.00%19,311,625

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 0

View all →
Insider% of sharesShares
No insiders recorded yet.

Institutional holders 0

HolderValue% of shares
No institutional holders on file.

Activity

—View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
No activity matches these filters.

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Lincoln Alternative Strategies LLCPassive13G/A—0—
Gavrilov Ognian AnguelovPassive13G———